JOHN DUONG: Open Payments
NPI 1407435647 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 52 payments from 15 companies in 2025. Trend: 2023 $418 · 2024 $1,158 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $397 |
| Lilly USA, LLC | 6 | $111 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Amgen Inc. | 3 | $44 |
| PFIZER INC. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
Products named: Ozempic, Wegovy, MOUNJARO, XIFAXAN, Rybelsus, TRELEGY ELLIPTA, AIRSUPRA, SHINGRIX.
Industry payments across FL — which companies pay providers there.
